The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot.The investigation determined the reported ventricular tachycardia appears to be related to patient morphology/pathology.The reported patient effect of ventricular tachycardia, as listed in the mitraclip system instructions for use, is a known possible complication associated with mitraclip procedures.There is no indication of a product issue with respect to manufacture, design or labeling.
|
This will be filed to report during the procedure, the patient experienced ventricular tachycardia requiring medical intervention.It was reported that this was a mitraclip procedure to treat functional mitral regurgitation (mr) with grade 4.The patient had ventricular tachycardia (vt) prior to the procedure.Two clips were implanted reducing mr to <1.During the procedure, vt continued to occur; therefore, a cardioverter defibrillator was placed to treat the vt.There was no issue with the mitraclip devices during the procedure.No additional information was reported.
|